Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma

Laboratory Investigation

Volumn 81, Issue 3, 2001, Pages 419-426

  Tort, Frederic ^a   Pinyol, Magda ^a   Pulford, Karen ^b   Roncador, Giovanna ^b   Hernandez, Lluis ^a   Nayach, Iracema ^a   Kluin Nelemans, Hanneke C ^c   Kluin, Philip ^c   Touriol, Christian ^d   Delsol, Georges ^d   Mason, David ^b   Campo, Elias ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MOESIN;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CASE REPORT; CHROMOSOME BREAKAGE; ENZYME ACTIVATION; GENE DELETION; GENE FUSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; INTRON; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 0035086796     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780249     Document Type: Article

References (42)

1. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells
2. Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations
3. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
4. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphomas is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35)
5. Regulation of cortical structure by the ezrin-radixin-moesin protein family
6. Isolation and characterization of the human nucleophosmin/b23 (NPM) gene: Identification of the YY1 binding site at the 5′ enhancer region
7. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth
8. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)
9. Molecular detection of the (2; 5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction
10. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
11. Evidence for ERM binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions
12. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)
13. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations
14. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
15. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
16. High incidence of the t(2; 5)(p23; q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p-80 immunostaining
17. Expression of the ALK tyrosine kinase gene in neuroblastoma
18. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis
19. CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35
20. Double immunofluorescence labelling of routinely processed paraffin sections
21. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation
22. Differential expression of moesin in cells of hematopoietic lineage and lymphatic systems
23. A new variant chromosomal translocation t(2; 2)(p23; q23) in CD30+/Ki-I+ anaplastic large cell lymphoma
24. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
25. ALK, the chromosome 2 gene locus altered by the t(2; 5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase
26. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2)
27. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements
28. Immunohistochemical screening for oncogenic tyrosine kinase activation
29. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma
30. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
31. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family
32. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule
33. t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma
34. A novel variant translocation t(2;13)(p23;q34) in Ki-1 large cell anaplastic lymphoma
35. Genomic DNA amplification and the detection of t(2;5)(p23; q35) in lymphoid neoplasms
36. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
37. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
38. ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction
39. ERM (ezrin/radixin/moesin) family: From cytoskeleton to signal transduction
40. Cortical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins
41. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma
42. Chromosome translocation based on illegitimate recombination in human tumors